
Health leader condemns ‘black service, not NHS service' received by mother
Lord Victor Adebowale, chairman of the NHS Confederation, described the death of his 92-year-old mother as 'undignified'.
His mother Grace, who worked as an NHS nurse for 45 years, died in January of suspected lung cancer.
But her cancer was not detected until after she died.
Her case highlights systemic racial disparities in healthcare, Lord Adebowale said.
'I just think there are too many situations where people that look like me and shades of me don't get the service,' he said.
In an emotional speech, Lord Adebowale told the NHS ConfedExpo conference in Manchester: 'It was not the dignified death that we would have wanted for her. It wasn't the death she deserved.
'So it makes me clear about the need to address the inequity. I think she got a black service, not an NHS service.
'So I have to address the inequity that still exists within the NHS, in terms of the experiences that people who look like me continue to receive.
'It just hasn't got any better.'
Grace Amoke Owuren Adebowale died in January (Family Handout/PA)
He went on: 'It is not acceptable that someone who looks like me, on average waits 20 minutes longer in A&E than white patients.
'To achieve an inclusive, equitable NHS we need an inclusive equitable culture from top to bottom.'
Mrs Adebowale emigrated from Nigeria to Scotland in the 1950s.
Lord Adebowale, who grew up in Wakefield, said that he did not want to blame anyone, but he said that he wanted to highlight a 'systematic problem'.
'She lived to the age of 92 and you may think, 'well, she had the good old innings', but for a lot of those years she was in some discomfort, and it looks like she died from cancer,' he told reporters.
'It's still the case that if you look like me, you're more likely to discover that you've got cancer in A&E, and that that for me is it's an example of two different services.
'I used the phrase 'black service'… you only have to look at the stats – across all the major disease categories that we talk about, black people have a worse experience and worse outcomes – we've known that for years, I'm not saying anything new.
'My mother is an episodic example of a systematic problem.
'We've got a cancer programme, we've got a cancer we've had targets for diagnostics, and pathways, and yet, people like my mother…'
Lord Adebowale, who established the NHS Race and Health Observatory in 2021 to try and tackle inequalities experienced by black and minority ethnic patients in healthcare, went on: 'I just think there are too many, too many situations where people that look like me and shades of me don't get the service.
'What I'm talking about is a systemic problem exampled by what I have experienced a my mum, and I think she represents a lot of other mums out there and lots of other people out there.'
Asked about his comments about a 'black service', Lord Adebowale went on: 'Why did I (say) it? Because I'm sick of it not changing like everyone else, and I'm close enough to it to know that it happens.
'I could have stood there and give you a load of stats, and you wouldn't be talking to me.
'And my mum, I think, God bless her, I think she would have wanted me to say it.'
He added: 'The disproportionate poor services that too many poor people and too many black people experience, that's what I'm sick of.'
He said there was nothing in his mother's medical records to suggest she had cancer, adding: 'She went to A&E in a poor condition.
'My sister described a hospital that was really struggling when she went in, she had to argue for mum to get a room.
'It was a very busy day. There had to be a negotiation to find a space, which you shouldn't have to do, but that's what happens when people are under pressure.'
He added: 'We haven't got to the bottom of it, and that's why I'm not blaming anybody, and I don't want to, but I can talk about my experience and my observation of what happened to my mum.
'How does that happen? I know it does happen. People have chronic diseases and people don't know and they die of them – I know it's more likely to happen if you're black, it's also more likely to happen if you're poor.
'It's all part of the same story. I used to own story to illustrate a bigger problem, which is systemic.'
On his mother, whose full name was Grace Amoke Owuren Adebowale and who worked in various nursing sectors including mental health, acute care and maternity, he said: 'If you a nurse it is what you are, it's what you're born to do.'
Commenting on Lord Adebowale's remarks, Professor Habib Naqvi, chief executive of the NHS Race and Health Observatory, said: 'We extend our sincere condolences, thoughts and support to Lord Victor and the Adebowale family.
'The loss of a beloved family member is extremely difficult. We thank Victor for the candour in sharing his personal testimony.
'The NHS Race and Health Observatory continues to support healthcare organisations in implementing meaningful change for ethnic minority patients, communities, and members of the healthcare workforce.'
Kate Seymour, from the charity Macmillan Cancer Support, said: 'Stories like Grace Amoke Owuren Adebowale's highlight the heartbreaking reality for some when it comes to accessing cancer care in this country.
'It is categorically unacceptable that some people with cancer are having worse experiences simply because of who they are or where they live.'
An NHS spokesperson said: 'Everyone – no matter their background – should receive the best NHS care possible.
'That's why we are working across the NHS to ensure that happens – from improving access to cancer diagnosis and treatment, to expanding health checks for Black and Asian communities and increasing uptake of blood pressure and cholesterol medication in under-served groups.
'But we know there is much more to do, and tackling health inequalities will form an important part of the upcoming 10 Year Health Plan.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Telegraph
23 minutes ago
- Telegraph
NHS faces paying more for US drugs to avoid future Trump tariffs
Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug pricing to take into account the 'concerns of the president', according to documents released after a trade agreement was signed earlier this year. White House sources said it expected the NHS to pay higher prices for American drugs in an attempt to boost the interests of corporate America. A Westminster source said: 'There's an understanding that we would look at the drug pricing issue in the concerns of the president.' The disclosure is likely to increase concerns about American interference in the British health service, which has long been regarded as a flashpoint in trade talks. It comes after Rachel Reeves announced a record £29 billion investment in the NHS in last week's spending review. The Chancellor's plans will drive spending on the health service up towards 50 per cent of all taxpayer expenditure by the mid-2030s, according to economists at the Resolution Foundation. The Telegraph has also learnt that under the terms of the trade deal with America, the UK has agreed to take fewer Chinese drugs, in a clause similar to the 'veto' given to Mr Trump over Chinese investment in Britain. The White House has asked the UK for assurances that steel and pharmaceutical products exported to the US do not originate in China, amid fears the deal could be used to 'circumvent' Mr Trump's punishing tariffs on Beijing. Mr Trump is enraged by how much more America pays for drugs compared with other countries and considers it to be the same issue as he has raised on defence spending. Just as the US president has heaped pressure on European nations to increase the GDP share they allocate to defence, he thinks they should spend more on drug development. An industry source said: 'The way we've been thinking about it and many in the administration have been thinking about it, it's more like the model in Nato, where countries contribute some share of their GDP.' Britain and the US 'intend to promptly negotiate significantly preferential treatment outcomes on pharmaceuticals and pharmaceutical ingredients', the trade deal reads. Pharmaceutical companies are also pushing for reductions in the revenue sales rebates they pay to the NHS under the voluntary scheme for branded medicines pricing, access and growth (VPAG) – a mechanism that the UK uses to make sure the NHS does not overpay. Non-US countries are 'free-riding' Last week, Albert Bourla, Pfizer's chief executive, said non-US countries were 'free-riding' and called for a US government-led push to make other nations increase their proportionate spend on innovative medicines. He said White House officials were discussing drug prices in trade negotiations with other countries. 'We represent in UK 0.3pc of their GDP per capita. That's how much they spend on medicine. So yes, they can increase prices,' Mr Bourla said. Industry sources said there was no indication yet on what the White House would consider to be a fair level of spending. Whatever the benchmark, Britain will face one of the biggest step-ups. UK expenditure on new innovative medicines is just 0.28pc of its GDP, roughly a third of America's proportionate spending of 0.78pc of its GDP. Even among other G7 nations, the UK is an anomaly. Germany spends 0.4pc of its GDP while Italy spends 0.5pc. Most large pharmaceutical companies generate between half and three quarters of their profits in the US, despite the fact that America typically makes up less than a fifth of their sales. This is because drug prices outside of the US can cost as little as 30pc of what Americans pay. Yet, pharmaceutical companies rely on higher US prices to fund drug research and development, which the rest of the world benefits from. A month ago, Mr Trump signed an executive order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients', which hit out at 'global freeloading' on drug pricing. It stated that 'Americans should not be forced to subsidise low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States' and ordered his commerce secretary to 'consider all necessary action regarding the export of pharmaceutical drugs or precursor material that may be fuelling the global price discrimination'. Trung Huynh, the head of pharma analysis at UBS, said: 'The crux of this issue is Trump thinks that the US is subsidising the rest of the world with drug prices. 'The president has said he wants to equalise pricing between the US and ex-US. And the way he wants to do it is not necessarily to bring down US prices all the way to where ex-US prices are, but he wants to use trade and tariffs as a pressure point to get countries to increase their prices. 'If he can offset some of the price by increasing prices higher ex-US, then the prices in America don't have to go down so much.' Mr Huynh added: 'It's going to be very hard for him to do. Because [in the UK deal] it hinges on the NHS, which we know has got zero money.' Under VPAG, pharmaceutical companies hand back at least 23pc of their revenue from sales of branded medicines back to the NHS, worth £3bn in the past financial year. The industry is pushing for this clawback to be cut to 10pc, which would mean the NHS would have to spend around 1.54bn more on the same medicines on an annual basis. The Government has already committed to reviewing the scheme, a decision which is understood to pre-date US trade negotiations. A government spokesman said: 'This Government is clear that we will only ever sign trade agreements that align with the UK's national interests and to suggest otherwise would be misleading. 'The UK has well-established and effective mechanisms for managing the costs of medicines and has clear processes in place to mitigate risks to supply.'


Daily Mail
an hour ago
- Daily Mail
Lucy Letby supporter claims neo-natal unit where baby serial killer worked was 'not fit for purpose'
The Countess of Chester Hospital's neo-natal unit was 'not fit for purpose' before Lucy Letby started murdering babies, a former nurse who worked there has claimed. Michele Worden said redundancies led to a loss of senior staff and plumbing issues created a 'perfect storm' for care failings. The former advanced nurse practitioner left the Countess after being made redundant in 2007, four years before Letby started working and eight years before her killing spree began. She told the Nursing Times that when the unit was downgraded in around 2006 and stopped caring for very premature babies under 27 weeks, senior nurses were replaced with junior staff who were asked to care for infants 'above their capabilities [and] training.' She said: 'It wasn't just the neonatal unit that wasn't fit for purpose, the whole maternity and paediatric and gynaecology… was not fit for purpose. 'The problems with the sewage and blocked sinks were not just [on] the neonatal unit, it was on the labour ward, it was all over.' Ms Worden said she believed the situation at the Countess of Chester was 'no different' to other NHS hospitals where maternity scandals have been uncovered in recent years. 'Hopefully Lucy will be exonerated,' she said. 'Chester is no different than Shrewsbury, Nottingham, Morecambe Bay. Women and children's healthcare has never been a high priority.' Letby, 38, is serving 15 whole life terms after being convicted of the murder of seven babies and attempted murder of seven more, including one baby girl she tried to kill twice. Plumber Lorenzo Mansutti, estates manager at the Countess, was the only witness called by Letby in her defence at her Manchester Crown Court trial. He admitted drainage problems were a 'weekly' issue at the hospital's 50-year-old Women's and Children's Building and told the jury that he remembered an incident when raw sewage backed up into sinks in the intensive care nursery. But he said it was a 'one off' and insisted that at no point were staff unable to wash their hands because the hospital had 'backup' portable handwashing units on site. The problem was not logged as a formal incident, so no exact date for the incident could be found. Letby's trial heard that none of the seven babies who died collapsed due to a bacterial infection associated with poor sewage. Cheshire police are continuing to investigate the former nurse and last year confirmed they had questioned her in prison in connection with more baby deaths. But, following a presentation from 14 international experts in February, who claim none of the babies were murdered but died due to poor care, there has been a continued chorus of people questioning the safety of her convictions. Letby has twice applied and been refused leave to appeal, but her new legal team have submitted a file of evidence to the Criminal Cases Review Commission, the body that investigates potential miscarriages of justice, in a last ditch attempt to get her convictions overturned. They claim the testimony of lead prosecution expert Dewi Evans was biased and that he changed his mind over the method of murder of one of the children murdered by Letby, a boy known as Baby C. Dr Evans has denied this and the Court of Appeal has already dismissed claims he was not suitably qualified or lacked independence. Yesterday it emerged that Dr Evans, who has been subjected to intense trolling online from Letby supporters, had been involved in an online row with one of them - an anonymous statistician who Dr Evans accused of being motivated by a sexual attraction to Letby. According to the statistician, Dr Evans wrote: 'You seem very intense, and it's not unusual for men to have the hots for pretty young blonde females. A nursing uniform is a turn-on for some by all accounts. 'I would suggest you need to get out more, find yourself an available pretty young blonde female, with/without nursing credentials. But one who doesn't go to work intent on murdering her patients.' The statistician said it was 'absurd' to say he believed Letby was innocent because she was 'blonde and pretty' and insisted he had come to that view after reviewing the transcripts of the trial.


BBC News
3 hours ago
- BBC News
Completion of £16m Trowbridge medical centre 'firmly in sight'
The completion of a £16m integrated care centre is "firmly in sight" following the installation of a new roof. The Trowbridge Integrated Care Centre in Wiltshire has been described as a "state-of-the-art health and care facility" and is due to open to patients early next site will become the location for the minor injury unit and X-ray department that are currently based within the nearby Trowbridge Community executive lead for cancer, planned care and community, Caroline Holmes, said: "The building work is well under way, the finish line is firmly in sight, and local people can now see their new integrated care centre really begin to take shape. Using the latest green technology, such as solar panels and heat pumps, the centre is designed to be fully self-sufficient and net zero carbon. Representatives from Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board (ICB) marked the "milestone" occasion on the recently installed were joined by the Mayor of Trowbridge, along with a number of NHS colleagues who will soon call the new centre Holmes thanked those who had helped bring the new centre to added: "When the very first spades went in the ground, it was difficult to picture how a brand new health and care facility could emerge from what was essentially a very muddy field. Yet, here we are."The new centre is set to be a "flagship location" for local health and care, with teams from many different organisations, including HCRG Care Group, Avon and Wiltshire Mental Health Partnership and the Royal United Hospital, working together under one roof.